At the request of the Journal Editor and Sage Publishing, the following article has been retracted:
Jiang M, Zhu Y, Yu H. Ginsenoside 20(S)-Rg3 suppresses cell viability in esophageal squamous cell carcinoma via modulating miR-324-5p-targeted PSME3. Human & Experimental Toxicology. 2021;40(11):1974-1984. doi:10.1177/09603271211017311
Sage Publishing was made aware that this article was accepted for publication as a result of a peer review process that was compromised and contains indicators of third-party activity. The authors have explained that they undertook the research without any third-party assistance. However, the authors have been unable to provide any evidence or underlying raw data to support their authorship.
Due to concerns about the integrity of this research, the article has been retracted.
Y.H. disagrees with the retraction. All other authors did not respond for comment when notified of this retraction.
References
1.
TorreLABrayFSiegelRL, et al.Global cancer statistics, 2012. CA: Cancer J Clin2015; 65: 87–108.
2.
OhashiSMiyamotoSKikuchiO, et al.Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology2015; 149: 1700–1715.
3.
Jackie OhSHanSLeeW, et al.Emerging immunotherapy for the treatment of esophageal cancer. Exp Opin Investig Drugs2016; 25: 667–677.
4.
MillerKDSiegelRLLinCC, et al.Cancer treatment and survivorship statistics, 2016. CA: Cancer J Clin2016; 66: 271–289.
5.
ToshimitsuHHashimotoKTangokuA, et al.Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells. Cancer Lett2004; 211: 69–78.
6.
Cools-LartigueJSpicerJFerriLE. Current status of management of malignant disease: current management of esophageal cancer. J Gastrointest Surgery2015; 19: 964–972.
7.
RuWWangDXuY, et al.Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.). Drug Discov Ther2015; 9: 23–32.
8.
HuMYangJQuL, et al.Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. Food Funct2020; 11: 456–471.
9.
GaoQZhengJ. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A. Cell Prolif2018; 51: e12438.
10.
WangJTianLKhanMN, et al.Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness. Cancer Lett2018; 415: 73–85.
11.
ZhangFLiMWuX, et al.Erratum: 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the P53 pathway [Corrigendum]. Drug Des Devel Ther2019; 13: 3527–3528.
12.
ChenZWeiXShenL, et al.20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma. Cancer Sci2019; 110: 389–400.
13.
ZhouYZhengXLuJ, et al.Ginsenoside 20(S)-Rg3 inhibits the Warburg effect via modulating DNMT3A/MiR-532-3p/HK2 pathway in ovarian cancer cells. Cell Physiol Biochem2018; 45: 2548–2559.
14.
CuiMYaoXLinY, et al.Interactive functions of microRNAs in the miR-23a-27a-24-2 cluster and the potential for targeted therapy in cancer. J Cell Physiol2020; 235: 6–16.
15.
YuJChenSNiuY, et al.Functional significance and therapeutic potential of miRNA-20b-5p in esophageal squamous cell carcinoma. Mol Ther Nucleic Acids2020; 21: 315–331.
16.
ChenHYaoXDiX, et al.MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma. Cancer Lett2020; 483: 114–126.
17.
LiuMYuJWangD, et al.Epigenetically upregulated microRNA-602 is involved in a negative feedback loop with FOXK2 in esophageal squamous cell carcinoma. Mol Ther2019; 27: 1796–1809.
18.
JiangHHuangGZhaoN, et al.Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting as a sponge for miR-324-5p. J Exp Clin Cancer Res: CR2018; 37: 169.
19.
GuCZhangMSunW, et al.Upregulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1. Oncol Res2019; 27: 515–524.
20.
ZhengXZhouYChenW, et al.Ginsenoside 20(S)-Rg3 prevents PKM2-targeting miR-324-5p from H19 sponging to antagonize the Warburg effect in ovarian cancer cells. Cell Physiol Biochem2018; 51: 1340–1353.
21.
ZhengXChenWHouH, et al.Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer. Biomed Pharmacother2017; 85: 620–626.
22.
ZhangFLiMWuX, et al.20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des Devel Ther2015; 9: 3969–3987.
23.
LuJChenHHeF, et al.Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells. Clin Exp Pharmacol Physiol2020; 47: 1455–1463.
24.
TangBXuAXuJ, et al.MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. Int J Cancer2018; 142: 109–120.
25.
QianWCaiXQianQ, et al.lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p. Cell Death Dis2019; 10: 129.
26.
WangQYuJ. MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol2018; 96: 19–25.
27.
ShengSXieLWuY, et al.MiR-144 inhibits growth and metastasis in colon cancer by down-regulating SMAD4. Biosci Rep2019; 39: BSR201818952019.
28.
LinHZhouAJZhangJY, et al.MiR-324-5p reduces viability and induces apoptosis in gastric cancer cells through modulating TSPAN8. J Pharm Pharmacol2018; 70: 1513–1520.
29.
SongWGuoCChenJ, et al.Silencing PSME3 induces colorectal cancer radiosensitivity by downregulating the expression of cyclin B1 and CKD1. Exp Biol Med (Maywood, NJ)2019; 244: 1409–1418.
30.
YuLLiJJLiangXL, et al.PSME3 promotes TGFB1 secretion by pancreatic cancer cells to induce pancreatic stellate cell proliferation. J Cancer2019; 10: 2128–2138.
31.
YiZYangDLiaoX, et al.PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer. Exp Cell Res2017; 358: 87–93.
